There is also accrued evidence that DLBCL with concurrent rearrangement of MYC and BCL2 or BCL6, (also called double-hit lymphoma (DHL)) are characterized by dismal prognosis, as evidenced by median OS < 1.5 years, regardless of COO [11]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.